ETERNAL/BRITEST

永恒/全英

• 批准号: 10040111
• 金额: $ 43.74万
• 依托单位: BRITEST LIMITED
• 依托单位国家: 英国
• 项目类别: EU-Funded
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10040111
• 关键词: ETERNAL; BRITEST

ETERNAL aims to contribute to sustainable development of pharmaceutical manufacture, use and disposal, by using and promoting full life cycle approaches covering design, manufacture, usage, and disposal, assessing the environmental risks of not only the API and residues/metabolites, but other chemicals and by-products of the production process. This type of approach is essential to take into consideration the types of green manufacturing approach under consideration by the pharmaceutical industry, as evidenced by the range and scope of case studies being undertaken within ETERNAL. Specific application of our risk and life cycle assessment approaches to the ETERNAL case studies is a key element of the proposed work and will provide industry and policymakers with key examples of how whole life cycle assessment may be used to evaluate the changes in environmental impacts expected due to the introduction of green manufacturing processes.no public description

永恒的目标是通过使用和促进涵盖设计、制造、使用和处置的全生命周期方法，不仅评估原料药和残留物/代谢物的环境风险，而且评估生产过程中的其他化学品和副产品，为药品制造、使用和处置的可持续发展做出贡献。考虑到制药业正在考虑的绿色制造方法的类型，这种方法是至关重要的，正如正在进行的案例研究的范围和范围所证明的那样。将我们的风险和生命周期评估方法具体应用于永恒的案例研究是拟议工作的一个关键要素，并将为行业和政策制定者提供关键范例，说明如何使用全生命周期评估来评估由于引入绿色制造工艺而预期的环境影响变化。